Brief: SSY Group Got Approvals For Drug Production And Registration From NMPA China
07/08/2024 02:10
Aug 7 (Reuters) - SSY Group Ltd 2005.HK :
* GOT APPROVALS FOR DRUG PRODUCTION AND REGISTRATION FOR
ENTACAPONE, LEVODOPA AND CARBIDOPA TABLETS, FLUVOXAMINE MALEATE
TABLETS
* OBTAINED APPROVALS FROM NMPA OF CHINA
Further company coverage: 2005.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth